Ref ID: 18805
Author:
M. Giannella, MD – Clinical Researcher1, P. Munoz, MD, PhD – Professor 1, J. Martinez Alarcon, MD – Microbiologist 2, P. Grossi, MD – Professor 3, E. Bouza, MD, PhD – Professor 1, on behalf of the PISOT study group;
Author address:
1Hosp. Gregorio Maranon, Madrid, Spain, 2Hosp. de Ciudad Real, Ciudad Real, Spain, 3Univ. of Insubria, Varese, Italy.
Full conference title:
52nd Annual ICAAC
Date: 9 September 2014
Abstract:
Background: Information on the current incidence, predisposing conditions, use of microbiological resources, etiology and outcome of pneumonia among patients with solid organ transplantation (SOT) is scarce. Methods: Italian and Spanish transplant centers were invited to report on all SOT patients with pneumonia occurring during 1 week in February 2012. The total amount of SOT patients under follow-up during the study week was requested to calculate the incidence of pneumonia. Results: 34 centers agreed to participate collecting 37 cases of pneumonia. Incidence of pneumonia during the study week resulted of 1.2 cases per 1,000 SOT patients followed. The cohort included: kidney (57%); heart (17%); liver (11%); lung (11%); lung-liver (3%) and kidney-pancreas (3%) recipients. The median age, Charlson score and Barthel index were 63 years (IQR 53-68), 5 (IQR 3-7) and 100 (IQR 85-100), respectively. Rates of chronic allograft dysfunction, retransplant in the past year, and biopsy proven rejection in the previous 3 months were 30, 8 and 3%, respectively. The onset of pneumonia after transplantation was late (>6 months) in 70% of patients. An attempt to microbiological diagnosis (≥ 1 sample) was made in all patients but one, with a diagnostic yield of 71.4%. Causative agents included: bacteria (76%), virus (40%), fungi (8%), and mixed infections (24%). P. aeruginosa, S. pneumoniae and Influenza virus were the most common pathogens. Reduction of immunosuppression therapy and use of immunoglobulins were done in 43 and 9% of patients, respectively. No case of in-hospital death was observed, 11% of patients required ICU admission and 26% experienced worsening of graft function. Univariate analysis showed that higher median PORT and CURB-65 scores were significantly (p8804;0.05) associated to ICU admission, while pneumonia caused by Aspergillus spp. and reduction of immunosuppression were associated to worsening of graft function. Conclusions: Preliminary data of our ongoing study showed a low incidence of pneumonia in SOT patients. Worsening of graft function was the most common complication.
Abstract Number: T-1041
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a